Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate (Q43704036)

26 November 2017

title

Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate (English)

1 reference

26 November 2017

Dierkes J

1

1 reference

26 November 2017

Westphal S

2

1 reference

26 November 2017

Kunstmann S

3

1 reference

26 November 2017

Banditt P

4

1 reference

26 November 2017

Lössner A

5

1 reference

26 November 2017

Luley C

6

1 reference

26 November 2017

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

158

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

161-164

1 reference

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

Plasma homocysteine levels and mortality in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

Serum homocysteine increases after therapy with fenofibrate or bezafibrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

Drug treatment of lipid disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

Determination of bezafibrate, ciprofibrate and fenofibric acid in human plasma by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

[High-performance liquid chromatographic method for the determination of fenofibric acid and reduced fenofibric acid in human blood, plasma and urine]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

Lipid-lowering drugs and homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

Implication of fibrate therapy for homocysteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

Homocysteine and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

Vitamin requirements for the treatment of hyperhomocysteinemia in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

Vitamins and minerals: efficacy and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

Vitamin nutrition status and homocysteine: an atherogenic risk factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900766-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(00)00766-8

1 reference

release_wfealvv5qzep7lr2julvwz3oma

26 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wfealvv5qzep7lr2julvwz3oma

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference